US Stock MarketDetailed Quotes

LPTX Leap Therapeutics

Watchlist
  • 2.3500
  • +0.2600+12.44%
Close Jul 12 16:00 ET
  • 2.2900
  • -0.0600-2.55%
Post 17:03 ET
89.92MMarket Cap-1880P/E (TTM)

Leap Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-22.17%-15.52M
10.79%-43.75M
20.24%-10.38M
14.40%-10.49M
16.92%-10.19M
-10.26%-12.7M
-39.50%-49.04M
-21.44%-13.01M
-51.23%-12.25M
-58.14%-12.26M
Net income from continuing operations
66.99%-13.82M
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
-35.51%-15.09M
-78.71%-17.02M
Operating gains losses
-93.77%16K
-97.86%13K
-34.86%-940K
-37.92%501K
-73.40%195K
209.36%257K
60.42%608K
-2,148.39%-697K
210.38%807K
468.22%733K
Depreciation and amortization
25.00%5K
-6.25%15K
0.00%4K
1.49%-199K
94.34%206K
-96.30%4K
-44.83%16K
-50.00%4K
-2,985.71%-202K
1,414.29%106K
Other non cash items
-99.66%100K
7,417.29%29.99M
9.28%106K
--306K
---100K
--29.68M
-24.29%399K
-53.59%97K
----
----
Change In working capital
-46.65%-3.07M
485.71%2.51M
193.74%1.66M
90.90%1.3M
-38.38%1.64M
5.81%-2.09M
-164.26%-651K
-68.54%-1.77M
-60.13%681K
232.50%2.66M
-Change in receivables
11.15%-247K
229.04%1.3M
102.89%23K
335.21%1.85M
50.50%-297K
-631.58%-278K
12.94%-1.01M
-291.13%-797K
132.32%426K
-152.10%-600K
-Change in prepaid assets
-43.51%-343K
-60.58%164K
138.24%81K
232.61%153K
186.44%169K
-186.28%-239K
165.10%416K
106.16%34K
-2.13%46K
6,000.00%59K
-Change in payables and accrued expense
-8.65%-2.39M
-24.66%712K
240.59%1.72M
-141.94%-624K
-40.47%1.81M
7.26%-2.2M
-75.77%945K
-25.59%-1.22M
-56.04%1.49M
176.75%3.05M
-Change in other current assets
-98.76%9K
199.07%748K
-133.76%-53K
101.86%22K
-78.13%56K
4,418.75%723K
-226.47%-755K
-73.70%157K
---1.18M
--256K
-Change in other current liabilities
2.00%-98K
-3.75%-415K
-10.31%-107K
-10.53%-105K
-0.98%-103K
5.66%-100K
1.48%-400K
45.20%-97K
-206.45%-95K
-198.08%-102K
-Change in other working capital
----
----
----
----
----
----
111.88%152K
----
----
----
Cash from discontinued investing activities
Operating cash flow
-22.17%-15.52M
10.79%-43.75M
20.24%-10.38M
14.40%-10.49M
16.92%-10.19M
-10.26%-12.7M
-39.50%-49.04M
-21.44%-13.01M
-51.23%-12.25M
-58.14%-12.26M
Investing cash flow
Cash flow from continuing investing activities
0
48.97M
0
0
-348K
49.32M
0
0
0
0
Net business purchase and sale
--0
--50.36M
--0
--0
--0
--50.36M
--0
--0
--0
--0
Net other investing changes
----
---1.39M
--0
--0
---348K
---1.05M
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--48.97M
--0
--0
---348K
--49.32M
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
200.00%29K
85.71%-30K
-1K
0
0
86.19%-29K
-100.21%-210K
0
0
0
Net common stock issuance
----
---1K
----
----
----
----
--0
----
----
----
Proceeds from stock option exercised by employees
200.00%29K
---29K
--0
--0
--0
---29K
--0
--0
--0
--0
Net other financing activities
----
----
----
----
----
----
-14.13%-210K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
200.00%29K
85.71%-30K
--0
---1K
--0
86.19%-29K
-100.21%-210K
--0
--0
--0
Net cash flow
Beginning cash position
7.85%70.64M
-43.00%65.5M
3.11%80.74M
0.59%91.42M
-1.15%102.04M
-43.00%65.5M
120.69%114.92M
-37.24%78.31M
154.33%90.88M
137.34%103.22M
Current changes in cash
-142.33%-15.49M
110.53%5.19M
20.24%-10.38M
14.40%-10.49M
14.08%-10.53M
411.97%36.59M
-178.33%-49.25M
-30.65%-13.01M
-113.74%-12.25M
-58.22%-12.26M
Effect of exchange rate changes
-370.00%-235K
73.46%-43K
35.92%280K
43.17%-183K
-15.38%-90K
-256.25%-50K
-390.91%-162K
94.34%206K
-161.79%-322K
-766.67%-78K
End cash Position
-46.18%54.92M
7.85%70.64M
7.85%70.64M
3.11%80.74M
0.59%91.42M
-1.15%102.04M
-43.00%65.5M
-43.00%65.5M
-37.24%78.31M
154.33%90.88M
Free cash flow
-22.17%-15.52M
10.79%-43.75M
20.24%-10.38M
14.40%-10.49M
16.92%-10.19M
-10.26%-12.7M
-39.50%-49.04M
-21.44%-13.01M
-51.23%-12.25M
-58.14%-12.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -22.17%-15.52M10.79%-43.75M20.24%-10.38M14.40%-10.49M16.92%-10.19M-10.26%-12.7M-39.50%-49.04M-21.44%-13.01M-51.23%-12.25M-58.14%-12.26M
Net income from continuing operations 66.99%-13.82M-49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M-35.51%-15.09M-78.71%-17.02M
Operating gains losses -93.77%16K-97.86%13K-34.86%-940K-37.92%501K-73.40%195K209.36%257K60.42%608K-2,148.39%-697K210.38%807K468.22%733K
Depreciation and amortization 25.00%5K-6.25%15K0.00%4K1.49%-199K94.34%206K-96.30%4K-44.83%16K-50.00%4K-2,985.71%-202K1,414.29%106K
Other non cash items -99.66%100K7,417.29%29.99M9.28%106K--306K---100K--29.68M-24.29%399K-53.59%97K--------
Change In working capital -46.65%-3.07M485.71%2.51M193.74%1.66M90.90%1.3M-38.38%1.64M5.81%-2.09M-164.26%-651K-68.54%-1.77M-60.13%681K232.50%2.66M
-Change in receivables 11.15%-247K229.04%1.3M102.89%23K335.21%1.85M50.50%-297K-631.58%-278K12.94%-1.01M-291.13%-797K132.32%426K-152.10%-600K
-Change in prepaid assets -43.51%-343K-60.58%164K138.24%81K232.61%153K186.44%169K-186.28%-239K165.10%416K106.16%34K-2.13%46K6,000.00%59K
-Change in payables and accrued expense -8.65%-2.39M-24.66%712K240.59%1.72M-141.94%-624K-40.47%1.81M7.26%-2.2M-75.77%945K-25.59%-1.22M-56.04%1.49M176.75%3.05M
-Change in other current assets -98.76%9K199.07%748K-133.76%-53K101.86%22K-78.13%56K4,418.75%723K-226.47%-755K-73.70%157K---1.18M--256K
-Change in other current liabilities 2.00%-98K-3.75%-415K-10.31%-107K-10.53%-105K-0.98%-103K5.66%-100K1.48%-400K45.20%-97K-206.45%-95K-198.08%-102K
-Change in other working capital ------------------------111.88%152K------------
Cash from discontinued investing activities
Operating cash flow -22.17%-15.52M10.79%-43.75M20.24%-10.38M14.40%-10.49M16.92%-10.19M-10.26%-12.7M-39.50%-49.04M-21.44%-13.01M-51.23%-12.25M-58.14%-12.26M
Investing cash flow
Cash flow from continuing investing activities 048.97M00-348K49.32M0000
Net business purchase and sale --0--50.36M--0--0--0--50.36M--0--0--0--0
Net other investing changes -------1.39M--0--0---348K---1.05M----------------
Cash from discontinued investing activities
Investing cash flow --0--48.97M--0--0---348K--49.32M--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 200.00%29K85.71%-30K-1K0086.19%-29K-100.21%-210K000
Net common stock issuance -------1K------------------0------------
Proceeds from stock option exercised by employees 200.00%29K---29K--0--0--0---29K--0--0--0--0
Net other financing activities -------------------------14.13%-210K--0--0--0
Cash from discontinued financing activities
Financing cash flow 200.00%29K85.71%-30K--0---1K--086.19%-29K-100.21%-210K--0--0--0
Net cash flow
Beginning cash position 7.85%70.64M-43.00%65.5M3.11%80.74M0.59%91.42M-1.15%102.04M-43.00%65.5M120.69%114.92M-37.24%78.31M154.33%90.88M137.34%103.22M
Current changes in cash -142.33%-15.49M110.53%5.19M20.24%-10.38M14.40%-10.49M14.08%-10.53M411.97%36.59M-178.33%-49.25M-30.65%-13.01M-113.74%-12.25M-58.22%-12.26M
Effect of exchange rate changes -370.00%-235K73.46%-43K35.92%280K43.17%-183K-15.38%-90K-256.25%-50K-390.91%-162K94.34%206K-161.79%-322K-766.67%-78K
End cash Position -46.18%54.92M7.85%70.64M7.85%70.64M3.11%80.74M0.59%91.42M-1.15%102.04M-43.00%65.5M-43.00%65.5M-37.24%78.31M154.33%90.88M
Free cash flow -22.17%-15.52M10.79%-43.75M20.24%-10.38M14.40%-10.49M16.92%-10.19M-10.26%-12.7M-39.50%-49.04M-21.44%-13.01M-51.23%-12.25M-58.14%-12.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg